AstraZeneca expands US manufacturing footprint to accelerate ambitions in next-generation cell therapy discovery and developmentBusiness Wire • 02/06/24
AstraZeneca facing three big investor debates as results loom, says BarclaysProactive Investors • 02/05/24
Astrazeneca (AZN) Q4 Earnings Preview: What You Should Know Beyond the Headline EstimatesZacks Investment Research • 02/05/24
History Says the Nasdaq Will Keep Soaring in 2024. Here's the Surprising Megacap Stock Wall Street Thinks Will Be the Biggest Winner.The Motley Fool • 02/03/24
AstraZeneca's mini acquisition spree comes as core oncology drugs face pressureProactive Investors • 02/02/24
GSK and AstraZeneca: A leading investment bank gives its verdict with an upgrade and a downgradeProactive Investors • 01/16/24
AstraZeneca, LSE and Heathrow among 320 co's to make nature-based disclosures in financial resultsProactive Investors • 01/16/24
Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract CancerPRNewsWire • 01/08/24
Omniose Announces Scientific Collaboration With AstraZeneca to Research Vaccines for Serious Bacterial DiseasesBusiness Wire • 01/05/24
Turbine Announces Collaboration to Uncover Biological Mechanisms of Drug Resistance in Hematological CancersBusiness Wire • 01/05/24